• Porcupine Inhibition in Sclerosteosis

  2026-09-01

  A 2025 Bone Research study tested LGK974-mediated porcupine inhibition as a pharmacological strategy for sclerosteosis, a severe high-bone-mass disorder caused by loss of functional sclerostin. Combined cell and mouse experiments showed reduced osteoblast activity and selected high-bone-mass features, while sex-dependent Axin2 responses and the absence of human data define important translational limits.

• γH2AX DNA Damage Detection Kit for FLASH-RT

  2026-08-31

  Turn radiation, nanoparticle, and genotoxicity experiments into a spatial readout of DNA double-strand breaks. This two-color workflow helps distinguish treatment-induced γ-H2AX signaling from staining artifacts while supporting microscopy, high-content screening, and DNA damage and repair research.

• Cytochalasin D for Actin-Dependent Uptake Assays

  2026-08-31

  Use Cytochalasin D to distinguish actin-dependent nanoparticle internalization from passive surface association in human corneal epithelial models. This practical workflow combines controlled cytoskeletal perturbation, pathway-focused uptake measurements, morphology checks, and viability controls.

• H5N1 mRNA Vaccine Protects Dairy Cows

  2026-08-30

  A hemagglutinin-based mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge and remained effective in most animals 19 weeks after initial vaccination. The study provides rare large-animal evidence that mRNA vaccination can combine a favorable safety profile with durable influenza protection, while also identifying important questions about immune correlates and field transferability.

• SAR405: A Selective Vps34 Inhibitor Workflow

  2026-08-29

  SAR405 gives researchers a precise way to interrogate Vps34-dependent PI3P production, autophagosome formation, and endolysosomal organization without broadly suppressing class I or II PI3Ks. This practical guide connects routine imaging assays with emerging nuclear PI3P and mismatch-repair workflows while emphasizing controls, handling, and interpretation.

• Liproxstatin-1: Ferroptosis Inhibitor Guide

  2026-08-29

  Liproxstatin-1 is a small-molecule ferroptosis inhibitor that suppresses lipid peroxidation-driven cell death. Product and preclinical evidence supports its use as a rescue control in ferroptosis research, including GPX4-deficient cell protection and a renal failure model.

• Rotavirus NSP4 Drives MLKL Necroptosis via Calcium

  2026-08-28

  This study identifies rotavirus NSP4 as the viral trigger that recruits RIPK1 and RIPK3 into an MLKL-activating necrosome. Its central advance is the demonstration that NSP4-driven endoplasmic reticulum calcium release promotes RIPK1–RIPK3 assembly, while RIPK1 contributes through a kinase-independent scaffolding function and RIPK3 retains kinase-dependent activity.

• Aneugen Assay Maps Microtubule Mechanisms

  2026-08-28

  Bernacki and colleagues describe a tiered flow-cytometric strategy that separates common aneugenic mechanisms involving tubulin destabilization, tubulin stabilization, and mitotic kinase inhibition. Across 27 reference chemicals, the combined biomarker and machine-learning workflow produced mechanism-level classifications that could improve interpretation of chromosome-missegregation assays.

• Viperin Targets nsp8 to Block Coronavirus Replication

  2026-08-27

  A 2026 study identifies a non-canonical antiviral mechanism in which viperin binds coronavirus nsp8, disrupts replication-transcription complex assembly, and suppresses RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work separates this protein-targeting pathway from ddhCTP-mediated chain termination and suggests a conserved host-directed entry point for antiviral drug development.

• (-)-Norepinephrine (+)-bitartrate: Research Guide

  2026-08-27

  (-)-Norepinephrine (+)-bitartrate, also called Norepinephrine bitartrate, is an adrenergic agonist used in cardiovascular, adrenergic signaling, and cardiomyopathy research. Its documented α1, α2A, and β1 receptor activity supports blood pressure regulation and heart rate modulation studies, while its salt form and light sensitivity require disciplined handling.

• AT13387: Hsp90 Chaperone Inhibition in Translation

  2026-08-26

  AT13387 offers translational researchers a structurally distinct way to interrogate Hsp90 chaperone inhibition, oncogenic client-protein stability, cell cycle arrest, and apoptosis induction. This article connects its cancer biology research applications with mechanistic lessons from a norovirus study while clearly separating established evidence from cross-domain hypotheses.

• HOXC8, Caspase-1, and Pyroptosis in Lung Cancer

  2026-08-26

  A 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional brake on caspase-1-driven pyroptosis in non-small cell lung carcinoma. The work links HOXC8 to HDAC1/2 recruitment at the CASP1 promoter and shows that disrupting this axis can activate inflammatory cell death and restrain tumor growth.

• NF 449 as a Selective P2X1 Antagonist

  2026-08-25

  The reference study established NF 449 as an exceptionally potent antagonist of recombinant rat P2X1-containing receptors by comparing homomeric and heteromeric P2X channels in a controlled electrophysiological system. Its subunit-resolved pharmacological profile provides a benchmark for interpreting ATP-gated signaling and for designing later platelet activation studies, while also defining important limits on direct translation to native tissues.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-25

  A 2026 FASEB Journal study developed chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21 expression, suppressed tumor-related cell-cycle programs, and reduced orthotopic tumor growth while limiting systemic distribution in mice.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-08-24

  Grafton and colleagues combined induced pluripotent stem cell-derived cardiomyocytes, high-content imaging, and deep learning to identify cardiotoxic phenotypes across compound libraries. Their single-parameter scoring framework provides a scalable, target-agnostic approach for detecting liabilities earlier in drug discovery, while also highlighting important limits in mechanism resolution and model transferability.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page